A drugmaker’s feud with the DEA is exacerbating the ADHD meds crisis — at a rate of 600 million missing doses a year.

A drugmaker’s feud with the DEA is exacerbating the ADHD meds crisis — at a rate of 600 million missing doses a year.

  • bramblepatchmystery@slrpnk.net
    1·
    9 months ago

    If we assume that people with ADHD are impervious to amphetamine addiction (as we were told) but have higher rates of methyl addiction, as I think you are insinuating, that’s actually a very great argument for not introducing amphetamines to people with ADHD.

    I’m not saying some of us don’t benefit from ADHD, I just think there are other options now in the market that aren’t turning 11 year old children into bona fide drug addicts.